The objective of this report is to provide a detailed analysis of the global market for Medical Marijuana. It is also to provide a comprehensive analysis of the leading companies producing these products, as well as the competitive environment they operate in. Marijuana (cannabis) remains a controversial drug in the twenty-first century. However, the potential role of specific cannabinoids for medical benefits will be revealed as the twenty-first century matures.
Marijuana is the most widely cultivated illicit drug plant worldwide. The international legal framework on drug control is provided by three United Nations Conventions, which instruct countries to limit drug supply and use to medical and scientific purposes. Nevertheless, there continues to be increasing debate over decriminalization, or even legalization of cannabis in particular.
This report provides an estimate of global cannabis production both in volume and value during the 2015-2020 period. The illicit use of marijuana dwarfs the medical use and that probably always will be the case. But to put global cannabis production in perspective, it is bigger than retail sales of all OTC (over-the-counter) analgesic pharmaceuticals by a factor of 9 and sales of pain medication pharmaceuticals by a factor of 25.
23 U.S. states and the District of Columbia now have legalized medical marijuana, and two states (Colorado and Washington state) allow for adult use (commonly referred to as recreational use). However, the focus in this report is on the Canada medical marijuana market, which is a new, emerging growth industry. The medical marijuana space in Canada, which went into effect in April 2014, has created conditions for a new highly regulated commercial industry with a limited amount of suppliers vetted extensively by Health Canada. Over $100 million in investment dollars have flowed into the Canadian medical marijuana industry already.
The future of medical marijuana lies in pharmaceutical products for the management of neuropathic pain, hypertension, post-stroke neuroprotection, multiple sclerosis, epilepsy, cancer, and other disorders.
Our reports have been used by over 10K customers, including:
115 pages •
By Infiniti Research Limited
• Mar 2018
About Medical Marijuana The global medical marijuana market covers the use of legally procured marijuana for the treatment of crucial symptoms of various chronic diseases impacting the global population. Serious injuries, migraines, back injuries resulting in fractures, arthritis, nerve damages, infections, and fibromyalgia...
121 pages •
By Infiniti Research Limited
• Mar 2018
About Cannabis Testing Cannabis testing is a key process conducted to ensure that safe products reach the consumer. The various types of tests conducted during cannabis testing are potency testing, terpene profiling, residual solvent screening, microbial analysis, and screening for pesticides and heavy metals. Technavio’s...
Cannabis, also known as marijuana, is a family of plants called Cannabaceae. There are more than 700 varieties of cannabis that have been described so far. Based on characteristics such as shape, color, height, smell, it is usually recognized by two main types: Cannabis Sativa, a native of the Western Hemisphere and...
58 pages •
By Euromonitor International
• Dec 2017
The tobacco industry has often been linked with a move into legal cannabis (largely without much substance in reality). However, in the context of a declining market for its core product and increasing acceptability of cannabis as a mainstream consumer product could such a move provide the industry with a continued stream of revenue into...
KEY FINDINGS The North American cannabis testing market is expected to grow at a CAGR of 12.99%, generating $1370 million by the end of the forecast period of 2017-2025. MARKET INSIGHTS The presence of major industry players such as Restec Corporation and Thermo Fisher Inc is hugely responsible...
KEY FINDINGS Cannabis is a psychoactive drug which is mainly used for medicinal and recreational purposes. The global cannabis testing market is expected to rise at a CAGR of 11.40% over the forecast period of 2017-2025. The market is mainly being driven by an increase in the number of testing facilities acquired as a strategic...